Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Mitigating Surprises: How Conversations with Caregivers Could Empower Young Cancer Patients to Determine their own Fertile Futures.

Hoffner B.

Narrat Inq Bioeth. 2017;7(2):132-136. doi: 10.1353/nib.2017.0041. No abstract available.

PMID:
29056642
2.

Narrative Symposium: Cancer and Fertility.

Yi A, De Michele G, Woodlief M, Fauvre M, Abrams R, Charne R, Warren TD, Ettinger B, Curran R, Rogers M, Hoffner B, Brown JJ, Schmuke AD, Mackey P, Frye J.

Narrat Inq Bioeth. 2017;7(2):111-E5. doi: 10.1353/nib.2017.0052. No abstract available.

PMID:
29056631
3.

Long-Term Follow-Up of Desmoid Fibromatosis Treated with PF-03084014, an Oral Gamma Secretase Inhibitor.

Villalobos VM, Hall F, Jimeno A, Gore L, Kern K, Cesari R, Huang B, Schowinsky JT, Blatchford PJ, Hoffner B, Elias A, Messersmith W.

Ann Surg Oncol. 2018 Mar;25(3):768-775. doi: 10.1245/s10434-017-6082-1. Epub 2017 Sep 8.

PMID:
28887726
5.

Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer.

Hamid O, Hoffner B, Gasal E, Hong J, Carvajal RD.

Cancer Immunol Immunother. 2017 Oct;66(10):1249-1264. doi: 10.1007/s00262-017-2025-8. Epub 2017 Jul 15. Review.

6.

Management of Patients With Skin Cancers: Basal Cell Carcinoma and Melanoma.

Hoffner B, Siegel DM.

J Adv Pract Oncol. 2017 Apr;8(3):244-248. Epub 2017 Apr 1. Review.

7.

We can study ultrarare tumors effectively in this day and age, it just takes a cooperative approach: The role of dasatinib in assorted indolent sarcomas.

Villalobos VM, Hoffner B, Elias AD.

Cancer. 2017 Jan 1;123(1):20-24. doi: 10.1002/cncr.30377. Epub 2016 Oct 3. No abstract available.

8.

Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.

Ribas A, Hamid O, Daud A, Hodi FS, Wolchok JD, Kefford R, Joshua AM, Patnaik A, Hwu WJ, Weber JS, Gangadhar TC, Hersey P, Dronca R, Joseph RW, Zarour H, Chmielowski B, Lawrence DP, Algazi A, Rizvi NA, Hoffner B, Mateus C, Gergich K, Lindia JA, Giannotti M, Li XN, Ebbinghaus S, Kang SP, Robert C.

JAMA. 2016 Apr 19;315(15):1600-9. doi: 10.1001/jama.2016.4059. Erratum in: JAMA. 2016 Jun 14;315(22):2472.

PMID:
27092830
9.

Programmed death 1 immune checkpoint inhibitors.

Trivedi MS, Hoffner B, Winkelmann JL, Abbott ME, Hamid O, Carvajal RD.

Clin Adv Hematol Oncol. 2015 Dec;13(12):858-68. Review.

PMID:
27058852
10.

Evolving Paradigms in Melanoma Therapy.

Olszanski AJ, Hoffner BW.

J Adv Pract Oncol. 2016 Apr;7(3):291-294. Epub 2016 Apr 1. Review. No abstract available.

11.

Administration and Handling of Talimogene Laherparepvec: An Intralesional Oncolytic Immunotherapy for Melanoma.

Hoffner B, Iodice GM, Gasal E.

Oncol Nurs Forum. 2016 Mar;43(2):219-26. doi: 10.1188/16.ONF.219-226.

PMID:
26906132
12.

Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma.

Flaherty DC, Hoffner BW, Lau BJ, Hamid O, Faries MB.

J Surg Oncol. 2015 Dec;112(8):844-5. doi: 10.1002/jso.24078. Epub 2015 Oct 26.

13.

A novel CCAAT/enhancer binding protein α germline variant in a case of acute myeloid leukemia.

Gutman JA, Hoffner B.

Leuk Lymphoma. 2012 May;53(5):1006-7. doi: 10.3109/10428194.2011.638718. Epub 2012 Jan 3. No abstract available.

PMID:
22066712
14.

"Entering a Clinical Trial: Is it Right for You?": a randomized study of The Clinical Trials Video and its impact on the informed consent process.

Hoffner B, Bauer-Wu S, Hitchcock-Bryan S, Powell M, Wolanski A, Joffe S.

Cancer. 2012 Apr 1;118(7):1877-83. doi: 10.1002/cncr.26438. Epub 2011 Aug 25.

15.

A draft sequence of the Neandertal genome.

Green RE, Krause J, Briggs AW, Maricic T, Stenzel U, Kircher M, Patterson N, Li H, Zhai W, Fritz MH, Hansen NF, Durand EY, Malaspinas AS, Jensen JD, Marques-Bonet T, Alkan C, Prüfer K, Meyer M, Burbano HA, Good JM, Schultz R, Aximu-Petri A, Butthof A, Höber B, Höffner B, Siegemund M, Weihmann A, Nusbaum C, Lander ES, Russ C, Novod N, Affourtit J, Egholm M, Verna C, Rudan P, Brajkovic D, Kucan Ž, Gušic I, Doronichev VB, Golovanova LV, Lalueza-Fox C, de la Rasilla M, Fortea J, Rosas A, Schmitz RW, Johnson PLF, Eichler EE, Falush D, Birney E, Mullikin JC, Slatkin M, Nielsen R, Kelso J, Lachmann M, Reich D, Pääbo S.

Science. 2010 May 7;328(5979):710-722. doi: 10.1126/science.1188021.

16.

Vaccination against the Human Papillomavirus: the lessons we have not learned.

Hoffner B.

Vaccine. 2009 Apr 6;27(16):2195-8. doi: 10.1016/j.vaccine.2008.10.016. Epub 2008 Oct 26.

PMID:
18955099
17.

From micrograms to picograms: quantitative PCR reduces the material demands of high-throughput sequencing.

Meyer M, Briggs AW, Maricic T, Höber B, Höffner B, Krause J, Weihmann A, Pääbo S, Hofreiter M.

Nucleic Acids Res. 2008 Jan;36(1):e5. Epub 2007 Dec 15.

18.

The dyskinesia identification system--Coldwater (DIS-Co): a tardive dyskinesia rating scale for the developmentally disabled.

Sprague RL, Kalachnik JE, Breuning SE, Davis VJ, Ullmann RK, Cullari S, Davidson NA, Ferguson DG, Hoffner BA.

Psychopharmacol Bull. 1984 Spring;20(2):328-38. No abstract available.

PMID:
6728999

Supplemental Content

Loading ...
Support Center